Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
17.25
0.39 (2.31%)
At close: Aug 15, 2025, 2:41 PM
Spyre Therapeutics Fail-to-Deliver
Total FTD Shares
14.22K
Below Average
FTD / Avg. Volume
2.65%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
Spyre Therapeutics Inc. has
14,218
shares failed to deliver, representing 2.65%
of the average daily volume of
536,743
shares. Over the past year, the monthly average FTD is
13,817
shares, with the current level 3% above
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 11, 2025 | 15.69 | 14.22K | +451.94% |
| Jun 30, 2025 | 14.97 | 2.58K | +203.06% |
| May 29, 2025 | 15.55 | 850 | +68.65% |
| Apr 30, 2025 | 15.23 | 504 | -72.40% |
| Mar 31, 2025 | 16.14 | 1.83K | +91200.00% |
| Feb 28, 2025 | 19.7 | 2 | -99.99% |
| Jan 31, 2025 | 22.99 | 15.51K | +1356.71% |
| Dec 31, 2024 | 23.28 | 1.06K | +11.87% |
| Nov 20, 2024 | 27.5 | 952 | -48.90% |
| Oct 31, 2024 | 32.53 | 1.86K | +194.78% |
| Sep 27, 2024 | 28.49 | 632 | +145.91% |
| Aug 30, 2024 | 28.75 | 257 | -24.19% |
| Jul 19, 2024 | 29.5 | 339 | -99.70% |
| Jun 28, 2024 | 23.51 | 111.61K | +19412.59% |
| May 29, 2024 | 32.06 | 572 | +57100.00% |
| Apr 23, 2024 | 34.25 | 1 | -99.93% |
| Mar 28, 2024 | 37.93 | 1.4K | +5074.07% |
| Feb 29, 2024 | 27.44 | 27 | -77.31% |
| Jan 26, 2024 | 27.5 | 119 | -60.07% |
| Dec 29, 2023 | 21.52 | 298 | -72.76% |
| Nov 30, 2023 | 18.66 | 1.09K | n/a |